Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2872 of 6351
-
Free groceries delivered to pregnant moms may reduce preterm births
Disease control Recruiting nowMedically tailored groceries (MTG), involving grocery items to be prepared at home, selected by a nutritional professional based on a treatment plan, is a growing approach adopted by healthcare systems to address food insecurity in their patient populations, a leading contributio…
Sponsor: Case Western Reserve University • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Can couples counseling help pregnant women with HIV stay healthy and beat depression?
Disease control Recruiting nowPrevention of mother-to-child transmission (PMTCT) of HIV virtually eliminates transmission of HIV from mothers to their infants. Adherence to PMTCT (i.e., to antiretroviral therapy, infant prophylaxis, and exclusive breastfeeding) during pregnancy and the postpartum period is ch…
Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Virtual reality may replace pills for Pre-Surgery jitters
Symptom relief Recruiting nowThis study will assess, on patients requesting a pharmacological premedication in the preoperative period, if virtual reality reality could reduce the request of pharmacological premedication while maintaining a good level of comfort for the patient. The aim of this study is to u…
Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
AI eye on your colon: can software spot polyps better?
Diagnosis CompletedThe goal of this clinical trial is to learn whether the ColoMaia II software can help doctors find colon lesions during colonoscopy and whether it is safe to use in adults aged 40 to 80 years having screening, surveillance, or diagnostic colonoscopy. The main questions it aims to…
Sponsor: MAIA Labs s.r.o. • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple injection ease chronic dry mouth?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if hyaluronic acid infiltration helps relieve dry mouth symptoms in adults with xerostomia. It will also assess the safety and duration of the treatment's effects. The main questions it aims to answer are: 1. Does hyaluronic acid impr…
Sponsor: University of Barcelona • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New antibiotic under the microscope: can it beat superbug infections?
Knowledge-focused Recruiting nowThis is a multicenter real-world observational cohort study designed to evaluate the effectiveness and safety of sulbactam-durlobactam in patients with carbapenem-resistant Acinetobacter baumannii (CRAB) infections. Patients receiving sulbactam-durlobactam will be compared with t…
Sponsor: Sichuan Provincial People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
New streaming fitness platform aims to get brain injury survivors moving
Symptom relief Recruiting nowMany physical fitness centers and online exercise programs are not designed to support people with intellectual and developmental disabilities. To address this, the investigators are collaborating with SPIRIT Club, a company specializing in fitness for people with disabilities, t…
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Experimental drug BL-M24D1 enters first human tests for tough cancers
Disease control Recruiting nowThis study is an open, multicenter, non-randomized phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M24D1 in patients with locally advanced or metastatic non-small cell lung cancer and other solid tumors.
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could stem cells repair damaged airways in kids?
Disease control Recruiting nowBronchiolitis obliterans (BO) is a chronic lung disease which was initiated with injury of the bronchiolar epithelium and resulted in nonuniform luminal obliteration or narrowing. Among children, the most common form of BO is post-infectious BO with a lack of treatment guidelines…
Early phase 1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for rare cartilage disease: five drugs put to the test
Disease control Recruiting nowOpen label pragmatic two-stage non-randomized trial comparing the effectiveness of five different standard of care treatment options for patients with relapsing polychondritis (RP).
Phase 2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for cancer patients: drug may prevent chemo weight loss
Symptom relief Recruiting nowCancer-associated anorexia, a debilitating condition characterized by progressive appetite loss in oncology patients, contributes to pancytopenia, sarcopenia, and adipose tissue depletion. Megestrol acetate (MA) improves appetite and promotes weight gain through multiple mechanis…
Phase 3 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Weekly shot could replace daily growth hormone for short kids
Disease control Recruiting nowThis study will take place at multiple sites and is divided into three phases:an initial 4-week getting-to-know-you phase,a 26-week main phase where participants receive medication,and a 4-week follow-up phase.Participants will be divided into three groups:two will receive differ…
Phase 2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New scaffold aims to speed up wound healing
Disease control Recruiting nowThe purpose of this research study is to evaluate the outcomes for patients managed with standard of care (SOC) wound treatments and those managed with standard of care treatment and tissue scaffolds, specifically Miro 3D. Tissue scaffolds like Miro 3D are 3-dimentional framework…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
New moms may get pain relief from pelvic floor therapy after birth tears
Symptom relief Recruiting nowThe aim of this study is to assess the effectiveness of a pelvic floor muscle training (PFMT) protocol associated with cryotherapy initiated in the immediate postpartum period in relieving pain in primiparous women who suffered perineal trauma during vaginal delivery. This is a h…
Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Can a common antidepressant help seniors sleep better?
Symptom relief Recruiting nowThis study aims to evaluate how effective trazodone is in treating insomnia in adults aged 65 years and older. The main question it aims to answer is : \- Is trazodone more effective than a placebo in reducing the severity of insomnia symptoms in older adults? Participants will…
Phase 2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Cancer patients with vein clots get a closer look: new study aims to fill treatment gap
Knowledge-focused Recruiting nowSuperficial venous thrombosis (SVT) is very common in clinical practice. What's more, around 15- 20% of SVTs occur in the context of cancer. Today, cancer patients are excluded from therapeutic trials for DVT. There is therefore no high-level evidence-based treatment recommendati…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New eczema drug shows promise in early trial
Disease control OngoingThe main purpose of this Ph2a study is to evaluate the preliminary efficacy, safety and tolerability of GIA632 when administered to adult participants with moderate to severe atopic dermatitis (AD).
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Electric current may boost Methotrexate's power against vitiligo
Disease control Not yet recruitingVitiligo is a common autoimmune depigmenting disorder characterized by selective destruction of melanocytes. Methotrexate (MTX) has shown potential in stabilizing disease activity and promoting repigmentation; however, systemic administration may cause hepatotoxicity. This pilot …
Sponsor: Pharos University in Alexandria • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Fiber fix for asthma? new study tests gut health link
Disease control Recruiting nowRandomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants will be supplemented to their target fiber dosage with either soluble fiber (Fr…
Phase 2 • Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Lifestyle program aims to cut colon cancer risk in high-risk individuals
Prevention Recruiting nowBackground Colorectal cancer is a significant health concern. For individuals identified as being at high risk for developing this disease, adopting healthy lifestyle behaviors is a powerful way to lower that risk. However, starting and maintaining these new habits can be challen…
Sponsor: China Medical University, China • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC